COWZ Pacer US Cash Cows 100 ETF

Expense Ratio
0.49%
Dividend
1.79%
Previous close
$69.24
Est. 12 months change
+12.84%
Projected Price
$78.13

Profitability Metrics

Return on Equity (ROE)
27.35%
Return on Assets (ROA)
8.57%
Return on Invested Capital (ROIC)
27.34%
Weighted Average Cost of Capital (WACC)
7.42%
ROIC - WACC
19.93%
Updated : 2026-08-07 18:05 ET

Valuation Metrics

P/E Ratio
17.24
Forward P/E
12.72
PEG Ratio
2.65
Debt Current Ratio
1.47

Growth & Cash Flow

Gross Margin
50.76%
Operating Margin
21.17%
FCF Margin
19.96%
TTM Revenue Growth
15.28%
Projected 12M EPS Growth
35.54%

Price Change

Price % from 50 SMA
7.32%
Price % from 200 SMA
10.98%
6 Months
8.15%
1 Year
25.39%
2 Years
28.82%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
BKNG2.21%
BMY2.18%
HCA2.08%
INTU2.04%
GD2.04%
MPC1.99%
VZ1.99%
T1.98%
CMCSA1.96%
GILD1.93%

ETF Analysis

Fund Overview

Pacer US Cash Cows 100 ETF (COWZ) currently reports 100 stock positions (subject to change), placing it in the moderately broad range by holdings breadth. The top line-up is BKNG (2.21%), BMY (2.18%), HCA (2.08%), with BKNG as the largest single weight at 2.21%. Together, the top three holdings account for 6.47%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Profitability & Capital Efficiency

Looking at how effectively the underlying holdings deploy capital, ROIC is 27.34%, WACC is 7.42%, and the economic spread is 19.93%. On balance, returns on invested capital exceed the cost of funding by a comfortable margin, which over time compounds favorably for long-term holders. Supporting metrics show ROE at 27.35% and ROA at 8.57%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

On an earnings multiple basis, trailing P/E of 17.24, forward P/E of 12.72, PEG of 2.65. The gap between trailing and forward multiples is not especially wide, suggesting the market is pricing a steadier earnings path rather than a sharp near-term re-rating. The PEG ratio is elevated, suggesting investors are paying a premium for the growth embedded in current earnings estimates. A current ratio reading of 1.47 suggests the portfolio's holdings carry less short-term financial cushion than the broader market average. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 50.76%, operating margin at 21.17%, and free cash flow margin at 19.96%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins are in good shape, consistent with businesses that maintain reasonable earnings conversion after overhead. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margins describe businesses that have earned their profitability rather than manufactured it through accounting — a meaningful quality signal.

Growth & Forward Outlook

On a forward-looking basis, TTM revenue growth of 15.28% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 12.97%, where the target distribution indicates incremental upside rather than outsized repricing. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Balancing the strengths against the areas of uncertainty, the weight of evidence favors an optimistic view with appropriate risk awareness.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.